RKL Wealth Management LLC Sells 704 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

RKL Wealth Management LLC reduced its position in Henry Schein, Inc. (NASDAQ:HSIC) by 10.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,840 shares of the company’s stock after selling 704 shares during the quarter. RKL Wealth Management LLC’s holdings in Henry Schein were worth $404,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. FMR LLC increased its stake in Henry Schein by 7.8% in the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after acquiring an additional 237,888 shares during the last quarter. Southpoint Capital Advisors LP grew its holdings in shares of Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares in the last quarter. Nuance Investments LLC grew its holdings in shares of Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC increased its position in shares of Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after purchasing an additional 71,560 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in Henry Schein by 1.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock valued at $82,464,000 after purchasing an additional 16,616 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on HSIC shares. UBS Group decreased their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Jefferies Financial Group increased their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective on the stock. Finally, Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Price Performance

HSIC opened at $74.59 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock’s 50 day simple moving average is $74.48 and its 200 day simple moving average is $72.51. The firm has a market cap of $9.26 billion, a price-to-earnings ratio of 30.70, a PEG ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the business posted $0.66 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.